Rigel Pharma (RIGL) Tops Q3 EPS by 146c

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Lake Street Reiterates Buy Rating on Quantum Computing, Inc. (QUBT)
• Innovative Eyewear posts 71% sales gain, adds retail partners